EEG technology and research is used for both clinical and research applications. However, a growing focus on consumer-oriented products capitalizes on public fascination with neuroscience, potentially drawing attention and investment away from the clinical research sector.
Can we suggest actionable measures/commitments for the EEG research community to add to our EEG manifesto to prevent a drain of resources away from clinical research?
To start you off, you may consider some of these questions:
- To what extent have recent EEG developments, such as high-density EEG and advanced signal processing techniques, significantly improved clinical diagnosis and treatment?
- What are the ethical implications of using AI-based EEG analysis in clinical settings, particularly regarding potential biases and limitations?
- How can we ensure that public funding for EEG research is allocated ethically and effectively, balancing the needs of both clinical and fundamental research?
- What are the potential risks and benefits of commercializing EEG technology, particularly in the context of neurotechnology startups and big tech companies?